Tolerogenic dendritic cells induce CD4+CD25 hiFoxp3+ regulatory T cell differentiation from CD4 +CD25-/loFoxp3- effector T cells

Journal of Immunology

Volumn 185, Issue 9, 2010, Pages 5003-5010

  Huang, Hui ^a   Dawicki, Wojciech ^b   Zhang, Xiaobei ^a   Town, Jennifer ^a   Gordon, John R ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 10 ANTIBODY; PROGRAMMED DEATH 1 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; INTERLEUKIN 2 RECEPTOR ALPHA; OVALBUMIN;

ANIMAL MODEL; ARTICLE; ASTHMA; CD4+ CD25+ T LYMPHOCYTE; CELL SELECTION; DENDRITIC CELL; DERMATOPHAGOIDES; EFFECTOR CELL; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LUNG; LYMPH NODE; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; REGULATORY T LYMPHOCYTE; SPLEEN; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; CELL DIFFERENTIATION; CELL SEPARATION; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ASTHMA; CELL DIFFERENTIATION; CELL SEPARATION; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; IMMUNE TOLERANCE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; OVALBUMIN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 78149490636     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903446     Document Type: Article

References (44)

1. Müller, G., A. Müller, T. Tüting, K. Steinbrink, J. Saloga, C. Szalma, J. Knop, and A. H. Enk. 2002. Interleukin-10-treated dendritic cells modulate immune responses of naive and sensitized T cells in vivo. J. Invest. Dermatol. 119:836-841.
2. Bellinghausen, I., U. Brand, K. Steinbrink, A. H. Enk, J. Knop, and J. Saloga. 2001. Inhibition of human allergic T-cell responses by IL-10-treated dendritic cells: differences from hydrocortisone-treated dendritic cells. J. Allergy Clin. Immunol. 108:242-249.
3. Steinbrink, K., M. Wölfl, H. Jonuleit, J. Knop, and A. H. Enk. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159:4772-4780.
4. Koya, T., H. Matsuda, K. Takeda, S. Matsubara, N. Miyahara, A. Balhorn, A. Dakhama, and E. W. Gelfand. 2007. IL-10-treated dendritic cells decrease airway hyperresponsiveness and airway inflammation in mice. J. Allergy Clin. Immunol. 119:1241-1250.
5. Lau, A. W., S. Biester, R. J. Cornall, and J. V. Forrester. 2008. Lipopolysaccharideactivated IL-10-secreting dendritic cells suppress experimental autoimmune uveoretinitis by MHCII-dependent activation of CD62L-expressing regulatory T cells. J. Immunol. 180:3889-3899.
6. Wakkach, A., N. Fournier, V. Brun, J. P. Breittmayer, F. Cottrez, and H. Groux. 2003. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18:605-617.
7. Perona-Wright, G., S. M. Anderton, S. E. Howie, and D. Gray. 2007. IL-10 permits transient activation of dendritic cells to tolerize T cells and protect from central nervous system autoimmune disease. Int. Immunol. 19:1123-1134.
8. Li, X., A. Yang, H. Huang, X. Zhang, J. Town, B. Davis, D. W. Cockcroft, and J. R. Gordon. 2010. Induction of type 2 T helper cell allergen tolerance by IL-10-differentiated regulatory dendritic cells. Am. J. Respir. Cell Mol. Biol. 42:190-199.
9. Nayyar, N., X. Zhang, F. Li, and J. R. Gordon. 2004. Therapeutic modulation of severe allergic lung disease using bone marrow-derived dendritic cells. Clin. Invest. Med. 27:123A (Abstr.).
10. Nayyar, A. 2009. Tolerogenic dendritic cell-induced tolerance induction in a mouse model of asthma. Doctoral dissertation, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
11. Henry, E., C. J. Desmet, V. Garzé, L. Fiévez, D. Bedoret, C. Heirman, P. Faisca, F. J. Jaspar, P. Gosset, A. P. A. Jacquet, et al. 2008. Dendritic cells genetically engineered to express IL-10 induce long-lasting antigen-specific tolerance in experimental asthma. J. Immunol. 181:7230-7242.
12. Mowat, A. M. 2003. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3:331-341.
13. Razmara, M., B. Hilliard, A. K. Ziarani, Y. H. Chen, and M. L. Tykocinski. 2008. CTLA-4 x Ig converts naive CD4+CD25-T cells into CD4+CD25+ regulatory T cells. Int. Immunol. 20:471-483.
14. Chen, W., W. Jin, N. Hardegen, K. J. Lei, L. Li, N. Marinos, G. McGrady, and S. M. Wahl. 2003. Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198:1875-1886.
15. Pyzik, M., and C. A. Piccirillo. 2007. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets. J. Leukoc. Biol. 82:335-346.
16. Siewert, C., U. Lauer, S. Cording, T. Bopp, E. Schmitt, A. Hamann, and J. Huehn. 2008. Experience-driven development: effector/memory-like alphaE+Foxp3+ regulatory T cells originate from both naive T cells and naturally occurring naivelike regulatory T cells. J. Immunol. 180:146-155.
17. Vukmanovic-Stejic, M., E. Agius, N. Booth, P. J. Dunne, K. E. Lacy, J. R. Reed, T. O. Sobande, S. Kissane, M. Salmon, M. H. Rustin, and A. N. Akbar. 2008. The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-specific memory response in vivo. J. Clin. Invest. 118:3639-3650.
18. Strickland, D. H., P. A. Stumbles, G. R. Zosky, L. S. Subrata, J. A. Thomas, D. J. Turner, P. D. Sly, and P. G. Holt. 2006. Reversal of airway hyperresponsiveness by induction of airway mucosal CD4+CD25+ regulatory T cells. J. Exp. Med. 203:2649-2660.
19. Gordon, J. R., F. Li, A. Nayyar, J. Xiang, and X. Zhang. 2005. CD8 alpha+, but not CD8 alpha-, dendritic cells tolerize Th2 responses via contact-dependent and-independent mechanisms, and reverse airway hyperresponsiveness, Th2, and eosinophil responses in a mouse model of asthma. J. Immunol. 175:1516-1522.
20. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693-1702.
21. Lutz, M. B., N. A. Kukutsch, M. Menges, S. Rössner, and G. Schuler. 2000. Culture of bone marrow cells in GM-CSF plus high doses of lipopolysaccharide generates exclusively immature dendritic cells which induce alloantigen-specific CD4 T cell anergy in vitro. Eur. J. Immunol. 30:1048-1052.
22. Schneider, A. M., F. Li, X. Zhang, and J. R. Gordon. 2001. Induction of pulmonary allergen-specific IgA responses or airway hyperresponsiveness in the absence of allergic lung disease following sensitization with limiting doses of ovalbumin-alum. Cell. Immunol. 212:101-109.
23. Vijayaraghavan, R., M. Schaper, R. Thompson, M. F. Stock, and Y. Alarie. 1993. Characteristic modifications of the breathing pattern of mice to evaluate the effects of airborne chemicals on the respiratory tract. Arch. Toxicol. 67:478-490.
24. Vijayaraghavan, R., M. Schaper, R. Thompson, M. F. Stock, L. A. Boylstein, J. E. Luo, and Y. Alarie. 1994. Computer assisted recognition and quantitation of the effects of airborne chemicals acting at different areas of the respiratory tract in mice. Arch. Toxicol. 68:490-499.
25. Mahnke, K., T. S. Johnson, S. Ring, and A. H. Enk. 2007. Tolerogenic dendritic cells and regulatory T cells: a two-way relationship. J. Dermatol. Sci. 46:159-167.
26. Misra, N., J. Bayry, S. Lacroix-Desmazes, M. D. Kazatchkine, and S. V. Kaveri. 2004. Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol. 172:4676-4680.
27. Houot, R., I. Perrot, E. Garcia, I. Durand, and S. Lebecque. 2006. Human CD4+CD25high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation. J. Immunol. 176:5293-5298.
28. Darrasse-Jèze, G., S. Deroubaix, H. Mouquet, G. D. Victora, T. Eisenreich, K. H. Yao, R. F. Masilamani, M. L. Dustin, A. Rudensky, K. Liu, and M. C. Nussenzweig. 2009. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med. 206:1853-1862.
29. Yamazaki, S., A. J. Bonito, R. Spisek, M. Dhodapkar, K. Inaba, and R. M. Steinman. 2007. Dendritic cells are specialized accessory cells along with TGF-for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3 precursors. Blood 110:4293-4302.
30. Coombes, J. L., and F. Powrie. 2008. Dendritic cells in intestinal immune regulation. Nat. Rev. Immunol. 8:435-446.
31. Akbari, O., R. H. DeKruyff, and D. T. Umetsu. 2001. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2:725-731.
32. Akdis, C. A., and M. Akdis. 2009. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J. Allergy Clin. Immunol. 123:735-746, quiz 747-748.
33. Stephens, G. L., J. Andersson, and E. M. Shevach. 2007. Distinct subsets of FoxP3+ regulatory T cells participate in the control of immune responses. J. Immunol. 178:6901-6911.
34. Steinbrink, K., E. Graulich, S. Kubsch, J. Knop, and A. H. Enk. 2002. CD4 (+) and CD8 (+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 99:2468-2476.
35. Randolph, D. A., and C. G. Fathman. 2006. Cd4+Cd25+ regulatory T cells and their therapeutic potential. Annu. Rev. Med. 57:381-402.
36. Toda, A., and C. A. Piccirillo. 2006. Development and function of naturally occurring CD4+CD25+ regulatory T cells. J. Leukoc. Biol. 80:458-470.
37. Hawrylowicz, C. M., and A. O'Garra. 2005. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat. Rev. Immunol. 5:271-283.
38. Stock, P., R. H. DeKruyff, and D. T. Umetsu. 2006. Inhibitionofthe allergic response by regulatory T cells. Curr. Opin. Allergy Clin. Immunol. 6:12-16.
39. Almeida, A. R., B. Rocha, A. A. Freitas, and C. Tanchot. 2005. Homeostasis of T cell numbers: from thymus production to peripheral compartmentalization and the indexation of regulatory T cells. Semin. Immunol. 17:239-249.
40. Yolcu, E. S., S. Ash, A. Kaminitz, Y. Sagiv, N. Askenasy, and S. Yarkoni. 2008. Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression. Immunol. Cell Biol. 86:650-658.
41. Lewkowich, I. P., N. S. Herman, K. W. Schleifer, M. P. Dance, B. L. Chen, K. M. Dienger, A. A. Sproles, J. S. Shah, J. Köhl, Y. Belkaid, and M. Wills-Karp. 2005. CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J. Exp. Med. 202:1549-1561.
42. Xystrakis, E., Z. Urry, and C. M. Hawrylowicz. 2007. Regulatory T cell therapy as individualized medicine for asthma and allergy. Curr. Opin. Allergy Clin. Immunol. 7:535-541.
43. Piccirillo, C. A., and A. M. Thornton. 2004. Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells. Trends Immunol. 25:374-380.
44. Curotto de Lafaille, M. A., and J. J. Lafaille. 2009. Natural and adaptive Foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 30:626-635.